Viewing Study NCT06752356


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2025-12-25 @ 9:20 PM
Study NCT ID: NCT06752356
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-16
First Post: 2024-12-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Sponsor: Kedrion S.p.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module